List view / Grid view
13 January 2015 | By Frost and Sullivan
Oncology, autoimmune and infectious diseases/vaccines are hot areas for novel therapeutics and in vitro diagnostics in 2015...
25 November 2014 | By Frost & Sullivan
Frost & Sullivan profiles key medical device manufacturers in the region, where the market is expected to grow at a CAGR of 3.1 percent between 2014 and 2018...
13 November 2014 | By Frost & Sullivan
Cloud service providers that offer guaranteed reliability and clear data portability terms will emerge as top contenders, finds Frost & Sullivan...
23 October 2014 | By Frost & Sullivan
Strong relationships with end users and an effective post sales service strategy must be a priority for wound care companies, says Frost & Sullivan...
22 October 2014 | By Frost & Sullivan
Etienne van Wyk, Programme Manager for Healthcare at Frost & Sullivan Africa, comments on the current outbreak and its long term implications...
30 September 2014 | By Frost & Sullivan
Distributors are expected to deploy a multi-sector, multi-brand strategy to broaden their business, says Frost & Sullivan...
7 April 2008 | By
Research within the pharmaceutical industry has tripled in the past 25 years, with the pipelines of the top companies doubling. Stricter regulations, guidelines, price and reimbursement legislation all result in a changing business environment. The growing market in drug development and increase in research and development (R&D) investment, including that…
7 April 2008 | By
In the highly competitive contract manufacturing outsourcing (CMO) market the industry is on the rise with pharmaceutical and biotechnology companies targeting their resources towards marketing, rather than production and drug discovery. Pharmaceutical and biopharmaceutical companies are faced with the need to outsource the manufacture of their products for a variety…
